Marwan Rasheed Mohammed1, Tarek Mahdy2,3, Anas Hashem4, Sabah Zaki1, Abdulwahid Alwahedi1, Hayder Makki1, Yaser Asaad1, Sameh Hany Emile5. 1. Al-Qassimi Hospital, Ministry of Health and Prevention (MOHAP), Sharjah, United Arab Emirates. 2. General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt. tmahdy@yahoo.com. 3. University Hospital Sharjah, Sharjah, United Arab Emirates. tmahdy@yahoo.com. 4. Division of gastroenterology and Hepatology, Mayo Clinic, 200 1st SW, Rochester, MN, USA. 5. General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt.
Abstract
BACKGROUND: Adolescent obesity is considered a public health challenge. Sleeve gastrectomy (SG) may be considered a safe option for treatment of adolescent obesity. This study aimed to assess the outcomes of SG in treatment of severe obesity in adolescents, with emphasis on the impact of baseline body mass index (BMI) and adherence to follow-up. METHODS: This was a single-center retrospective cohort study on adolescents with severe obesity who underwent SG at a tertiary referral bariatric center. The main outcome measures were weight loss, improvement in comorbidities at 12 months postoperatively, and complications. RESULTS: A total of 72 adolescent patients (47 female) of a mean BMI of 47.9 ± 7.1 kg/푚2 were enrolled in the study. The mean %TWL was 34.94 ± 9.35 and the mean %EWL was 73.47 ± 22.12. Complete remission was recorded in all patients with type 2 diabetes mellitus (DM), pre-DM, and sleep apnea, in 80% of patients with hypertension, and 57% of patients with hypothyroidism. The long-term complication rate after SG was 18%. Patients with higher preoperative BMI had significantly (p = 0.018) lower %EWL at 1 year. CONCLUSION: SG is an effective and safe surgical procedure for adolescents with severe obesity. It was associated with a significant weight loss, high comorbidity remission rates, and no mortality or serious complications. Lower baseline BMI and better adherence to follow-up were associated with better outcome of SG.
BACKGROUND:Adolescent obesity is considered a public health challenge. Sleeve gastrectomy (SG) may be considered a safe option for treatment of adolescent obesity. This study aimed to assess the outcomes of SG in treatment of severe obesity in adolescents, with emphasis on the impact of baseline body mass index (BMI) and adherence to follow-up. METHODS: This was a single-center retrospective cohort study on adolescents with severe obesity who underwent SG at a tertiary referral bariatric center. The main outcome measures were weight loss, improvement in comorbidities at 12 months postoperatively, and complications. RESULTS: A total of 72 adolescent patients (47 female) of a mean BMI of 47.9 ± 7.1 kg/푚2 were enrolled in the study. The mean %TWL was 34.94 ± 9.35 and the mean %EWL was 73.47 ± 22.12. Complete remission was recorded in all patients with type 2 diabetes mellitus (DM), pre-DM, and sleep apnea, in 80% of patients with hypertension, and 57% of patients with hypothyroidism. The long-term complication rate after SG was 18%. Patients with higher preoperative BMI had significantly (p = 0.018) lower %EWL at 1 year. CONCLUSION: SG is an effective and safe surgical procedure for adolescents with severe obesity. It was associated with a significant weight loss, high comorbidity remission rates, and no mortality or serious complications. Lower baseline BMI and better adherence to follow-up were associated with better outcome of SG.
Authors: Salman K Al-Sabah; Sulaiman M Almazeedi; Shaimaa A Dashti; Ahmed Y Al-Mulla; Daliya AlMohammad Ali; Talib H Jumaa Journal: Obes Surg Date: 2015-01 Impact factor: 4.129